STOCK TITAN

CXApp (NASDAQ: CXAI) issues 12.27M shares to Avondale in private deal

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

CXApp Inc. reported an unregistered sale of equity under a previously agreed financing arrangement. The company issued 12,267,843 shares of common stock to Avondale Capital, LLC under Pre-Paid Purchase #3, dated October 17, 2025, which stems from a Securities Purchase Agreement dated March 26, 2025.

The shares were issued between June 1 and June 3, 2026 at prices between $0.126216 and $0.126217 per share in a private transaction. CXApp relied on Section 4(a)(2) of the Securities Act, which allows offerings that do not involve a public offering, and included extensive cautionary language regarding forward-looking statements and related risks.

Positive

  • None.

Negative

  • None.

Insights

CXApp raised equity privately through a discounted share issuance to a single investor.

CXApp Inc. issued 12,267,843 common shares to Avondale Capital under a pre-paid purchase linked to a earlier Securities Purchase Agreement. The pricing between $0.126216 and $0.126217 per share suggests equity is being used as consideration under that structured financing.

The transaction relies on the Section 4(a)(2) exemption, meaning the shares were placed privately rather than via a public offering. Economic impact for existing holders depends on the company’s total shares outstanding and the role of this pre-paid facility in its broader funding needs, details not included in the excerpt.

The company also reiterates extensive forward-looking statement disclaimers, highlighting demand for its services, competitive and regulatory changes, customer concentration, and management continuity as important risk factors. Future periodic reports may elaborate on how this financing and these risks interact with its operating performance.

Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Shares issued 12,267,843 shares Common stock issued to Avondale Capital under Pre-Paid Purchase #3
Issue price range $0.126216–$0.126217 per share Pricing for shares issued June 1–3, 2026
Pre-Paid Purchase date October 17, 2025 Date of Pre-Paid Purchase #3 with Avondale
Securities Purchase Agreement date March 26, 2025 Agreement between CXApp and Avondale
Securities Act exemption Section 4(a)(2) Unregistered sale of equity securities
Unregistered Sales of Equity Securities regulatory
"Item 3.02 Unregistered Sales of Equity Securities."
Pre-Paid Purchase #3 financial
"under a Pre-Paid Purchase #3, dated as of October 17, 2025"
Securities Purchase Agreement regulatory
"pursuant to the Securities Purchase Agreement, dated as of March 26, 2025"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
Section 4(a)(2) of the Securities Act of 1933 regulatory
"in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended"
forward-looking statements regulatory
"This report includes “forward-looking statements” within the meaning"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001820875 0001820875 2026-06-03 2026-06-03 0001820875 cxai:CommonStockParValue0.0001PerShareMember 2026-06-03 2026-06-03 0001820875 cxai:WarrantsToPurchaseCommonStockMember 2026-06-03 2026-06-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 3, 2026 (June 3, 2026)

 

 

 

CXApp Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39642   85-2104918

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

  (I.R.S. Employer
Identification No.)

 

Four Palo Alto Square, Suite 200

3000 El Camino Real

California, CA

  94306
(Address of principal executive offices)   (Zip Code)

 

(650) 785-7171

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   CXAI   The Nasdaq Stock Market LLC
Warrants to purchase common stock   CXAIW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 3.02 Unregistered Sales of Equity Securities.

 

CXApp Inc. (the “Company”) issued an aggregate of 12,267,843 shares of common stock to Avondale Capital, LLC (“Avondale”) under a Pre-Paid Purchase #3, dated as of October 17, 2025, which was entered into pursuant to the Securities Purchase Agreement, dated as of March 26, 2025, by and between the Company and Avondale. The shares of common stock were issued between June 1, 2026 and June 3, 2026, at a price between $0.126216 and $0.126217 per share. The offer and sale of these shares of common stock was made in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended, for transactions not involving a public offering.

 

Cautionary Statement Regarding Forward-Looking Statements

 

This report includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The expectations, estimates, and projections of the Company may differ from its actual results and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” or the negative or other variations thereof and similar expressions are intended to identify such forward looking statements. These forward-looking statements include, without limitation, expectations with respect to future performance of the Company, including projected financial information (which is not audited or reviewed by the Company’s auditors), and the future plans, operations and opportunities for the Company and other statements that are not historical facts. These statements are based on the current expectations of the Company’s management and are not predictions of actual performance. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Factors that may cause such differences include, but are not limited to: the demand for the Company’s services together with the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors or changes in the business environment in which the Company operates; changes in consumer preferences or the market for the Company’s services; changes in applicable laws or regulations; the availability or competition for opportunities for expansion of the Company’s business; difficulties of managing growth profitably; the loss of one or more members of the Company’s management team; loss of a major customer and other risks and uncertainties included from time to time in the Company’s reports (including all amendments to those reports) filed with the Securities and Exchange Commission. The Company cautions that the foregoing list of factors is not exclusive. You should not place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing the Company’s assessments as of any date subsequent to the date of this communication.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CXApp Inc.
   
Date: June 3, 2026 By: /s/ Khurram P. Sheikh
  Name: Khurram P. Sheikh
  Title: Chairman and Chief Executive Officer

 

2

FAQ

What equity transaction did CXApp Inc. (CXAI) disclose in this 8-K filing?

CXApp Inc. disclosed issuing 12,267,843 shares of common stock to Avondale Capital, LLC. The issuance occurred under a pre-paid purchase arrangement connected to a March 26, 2025 Securities Purchase Agreement between CXApp and Avondale, using a private placement exemption.

Who received the newly issued CXApp Inc. (CXAI) shares and under what agreement?

Avondale Capital, LLC received the newly issued CXApp shares. The issuance was made under Pre-Paid Purchase #3 dated October 17, 2025, which was entered into pursuant to a Securities Purchase Agreement dated March 26, 2025 between CXApp Inc. and Avondale.

At what price were the new CXApp Inc. (CXAI) shares issued to Avondale Capital?

The shares were issued at prices between $0.126216 and $0.126217 per share. This narrow price range applied to shares issued between June 1, 2026 and June 3, 2026, reflecting how the pre-paid purchase arrangement translated into equity.

What securities law exemption did CXApp Inc. (CXAI) use for this share issuance?

CXApp relied on Section 4(a)(2) of the Securities Act of 1933. This provision allows sales that do not involve a public offering, meaning the 12,267,843 shares issued to Avondale Capital were treated as a private placement rather than a registered public sale.

Over what period did CXApp Inc. (CXAI) issue the 12,267,843 shares?

CXApp issued the 12,267,843 common shares between June 1, 2026 and June 3, 2026. All of these shares went to Avondale Capital under the existing Pre-Paid Purchase #3 arrangement linked to an earlier Securities Purchase Agreement.

What key risks does CXApp Inc. (CXAI) highlight alongside this equity issuance?

CXApp highlights risks around demand for its services, competitive and business conditions, regulatory changes, managing growth profitably, possible loss of management team members, and loss of a major customer, emphasizing that forward-looking statements may differ materially from actual results.

Filing Exhibits & Attachments

4 documents